Insulin delivery apparatuses capable of bluetooth data transmission

  • US 10,685,749 B2
  • Filed: 12/28/2015
  • Issued: 06/16/2020
  • Est. Priority Date: 12/19/2007
  • Status: Active Grant
First Claim
Patent Images

1. A system comprising:

  • a data receiver configured to receive, over a communication link, information corresponding to a detected glucose level of a user from an analyte sensor;

    an insulin infusion device communicatively coupled with the data receiver and configured to deliver insulin to the user'"'"'s body;

    one or more processors communicatively coupled with the data receiver and the insulin infusion device, at least one of the one or more processors programmed to control the delivery of insulin from the insulin infusion device based on the information corresponding to the detected glucose level of the user and a modified glucose level;

    a display unit communicatively coupled to the one or more processors and a memory, wherein the memory stores instructions that, when executed by the one or more processors, causes the one or more processors to simultaneously display on the display unit;

    a first representation of an insulin treatment parameter profile comprising a vertical basal insulin axis and a first trace line of basal insulin over a horizontal time scale represented by at least one time axis;

    a modified representation of the insulin treatment parameter profile comprising the vertical basal insulin axis and a second trace line of basal insulin over the horizontal time scale based on a detected horizontal and/or vertical user modification to the first trace line of basal insulin;

    a first representation of a physiological profile associated with the insulin treatment parameter profile comprising a vertical glucose parameter axis and a first trace line of a glucose parameter over the horizontal time scale; and

    a modified representation of the physiological profile comprising the vertical glucose parameter axis and a second trace line of the glucose parameter over the horizontal time scale based on a determined corresponding modification to the glucose parameter due to the detected user modification to the first trace line of basal insulin, wherein the second trace line of the glucose parameter comprises the modified glucose level.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×